Physiomics Awarded New Contract

AI SummaryClose X

Physiomics plc has secured a new contract with a South Korean biopharmaceutical client, valued at up to £66,600, to provide PK/PD modelling and simulation services for a clinical-stage oncology asset. This project, which is expected to conclude within two months, highlights Physiomics' expansion into new international markets and its role in supporting drug development decisions.

Disclaimer*

Companies

Physiomics (PYC)
UK 100

Latest directors dealings